Report Detail

Pharma & Healthcare Global Injection General Anesthetics Drug Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4753166
  • |
  • 05 October, 2026
  • |
  • Global
  • |
  • 121 Pages
  • |
  • GIR
  • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Injection General Anesthetics Drug market size was valued at US$ 2981 million in 2025 and is forecast to a readjusted size of US$ 3786 million by 2032 with a CAGR of 3.5% during review period.
Injection general anesthetics are a class of medications administered intravenously to induce a state of unconsciousness and insensitivity to pain during surgical procedures. These drugs work by rapidly and effectively altering brain function to produce loss of awareness and sensation. Unlike inhalational anesthetics, which are administered through the respiratory system, injection general anesthetics are delivered directly into the bloodstream, allowing for precise control over the depth and duration of anesthesia. Examples include propofol, which is known for its rapid onset and short duration of action, and thiopental, which has a longer history of use. These medications are crucial for various medical and surgical interventions, ensuring that patients remain comfortable and immobile throughout procedures.
This report is a detailed and comprehensive analysis for global Injection General Anesthetics Drug market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Injection General Anesthetics Drug market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Injection General Anesthetics Drug market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Injection General Anesthetics Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Injection General Anesthetics Drug market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Injection General Anesthetics Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Injection General Anesthetics Drug market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Aspen Pharma, Fresenius-Kabi, AbbVie, Baxter Healthcare, B.Braun, Maruishi, Piramal, Hikma Pharmaceuticals, Yichang Humanwell, Nhwa, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Injection General Anesthetics Drug market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Remifentanil
Propofol
Etomidate
Other
Market segment by Application
Hospital
Clinic
Other
Major players covered
Aspen Pharma
Fresenius-Kabi
AbbVie
Baxter Healthcare
B.Braun
Maruishi
Piramal
Hikma Pharmaceuticals
Yichang Humanwell
Nhwa
Hengrui
Xi'an Libang
Pfizer
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Injection General Anesthetics Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Injection General Anesthetics Drug, with price, sales quantity, revenue, and global market share of Injection General Anesthetics Drug from 2021 to 2026.
Chapter 3, the Injection General Anesthetics Drug competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Injection General Anesthetics Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Injection General Anesthetics Drug market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Injection General Anesthetics Drug.
Chapter 14 and 15, to describe Injection General Anesthetics Drug sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Injection General Anesthetics Drug Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Remifentanil
    • 1.3.3 Propofol
    • 1.3.4 Etomidate
    • 1.3.5 Other
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Injection General Anesthetics Drug Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Other
  • 1.5 Global Injection General Anesthetics Drug Market Size & Forecast
    • 1.5.1 Global Injection General Anesthetics Drug Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Injection General Anesthetics Drug Sales Quantity (2021-2032)
    • 1.5.3 Global Injection General Anesthetics Drug Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Aspen Pharma
    • 2.1.1 Aspen Pharma Details
    • 2.1.2 Aspen Pharma Major Business
    • 2.1.3 Aspen Pharma Injection General Anesthetics Drug Product and Services
    • 2.1.4 Aspen Pharma Injection General Anesthetics Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Aspen Pharma Recent Developments/Updates
  • 2.2 Fresenius-Kabi
    • 2.2.1 Fresenius-Kabi Details
    • 2.2.2 Fresenius-Kabi Major Business
    • 2.2.3 Fresenius-Kabi Injection General Anesthetics Drug Product and Services
    • 2.2.4 Fresenius-Kabi Injection General Anesthetics Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Fresenius-Kabi Recent Developments/Updates
  • 2.3 AbbVie
    • 2.3.1 AbbVie Details
    • 2.3.2 AbbVie Major Business
    • 2.3.3 AbbVie Injection General Anesthetics Drug Product and Services
    • 2.3.4 AbbVie Injection General Anesthetics Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 AbbVie Recent Developments/Updates
  • 2.4 Baxter Healthcare
    • 2.4.1 Baxter Healthcare Details
    • 2.4.2 Baxter Healthcare Major Business
    • 2.4.3 Baxter Healthcare Injection General Anesthetics Drug Product and Services
    • 2.4.4 Baxter Healthcare Injection General Anesthetics Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Baxter Healthcare Recent Developments/Updates
  • 2.5 B.Braun
    • 2.5.1 B.Braun Details
    • 2.5.2 B.Braun Major Business
    • 2.5.3 B.Braun Injection General Anesthetics Drug Product and Services
    • 2.5.4 B.Braun Injection General Anesthetics Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 B.Braun Recent Developments/Updates
  • 2.6 Maruishi
    • 2.6.1 Maruishi Details
    • 2.6.2 Maruishi Major Business
    • 2.6.3 Maruishi Injection General Anesthetics Drug Product and Services
    • 2.6.4 Maruishi Injection General Anesthetics Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Maruishi Recent Developments/Updates
  • 2.7 Piramal
    • 2.7.1 Piramal Details
    • 2.7.2 Piramal Major Business
    • 2.7.3 Piramal Injection General Anesthetics Drug Product and Services
    • 2.7.4 Piramal Injection General Anesthetics Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Piramal Recent Developments/Updates
  • 2.8 Hikma Pharmaceuticals
    • 2.8.1 Hikma Pharmaceuticals Details
    • 2.8.2 Hikma Pharmaceuticals Major Business
    • 2.8.3 Hikma Pharmaceuticals Injection General Anesthetics Drug Product and Services
    • 2.8.4 Hikma Pharmaceuticals Injection General Anesthetics Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Hikma Pharmaceuticals Recent Developments/Updates
  • 2.9 Yichang Humanwell
    • 2.9.1 Yichang Humanwell Details
    • 2.9.2 Yichang Humanwell Major Business
    • 2.9.3 Yichang Humanwell Injection General Anesthetics Drug Product and Services
    • 2.9.4 Yichang Humanwell Injection General Anesthetics Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Yichang Humanwell Recent Developments/Updates
  • 2.10 Nhwa
    • 2.10.1 Nhwa Details
    • 2.10.2 Nhwa Major Business
    • 2.10.3 Nhwa Injection General Anesthetics Drug Product and Services
    • 2.10.4 Nhwa Injection General Anesthetics Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Nhwa Recent Developments/Updates
  • 2.11 Hengrui
    • 2.11.1 Hengrui Details
    • 2.11.2 Hengrui Major Business
    • 2.11.3 Hengrui Injection General Anesthetics Drug Product and Services
    • 2.11.4 Hengrui Injection General Anesthetics Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Hengrui Recent Developments/Updates
  • 2.12 Xi'an Libang
    • 2.12.1 Xi'an Libang Details
    • 2.12.2 Xi'an Libang Major Business
    • 2.12.3 Xi'an Libang Injection General Anesthetics Drug Product and Services
    • 2.12.4 Xi'an Libang Injection General Anesthetics Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Xi'an Libang Recent Developments/Updates
  • 2.13 Pfizer
    • 2.13.1 Pfizer Details
    • 2.13.2 Pfizer Major Business
    • 2.13.3 Pfizer Injection General Anesthetics Drug Product and Services
    • 2.13.4 Pfizer Injection General Anesthetics Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Pfizer Recent Developments/Updates

3 Competitive Environment: Injection General Anesthetics Drug by Manufacturer

  • 3.1 Global Injection General Anesthetics Drug Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Injection General Anesthetics Drug Revenue by Manufacturer (2021-2026)
  • 3.3 Global Injection General Anesthetics Drug Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Injection General Anesthetics Drug by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Injection General Anesthetics Drug Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Injection General Anesthetics Drug Manufacturer Market Share in 2025
  • 3.5 Injection General Anesthetics Drug Market: Overall Company Footprint Analysis
    • 3.5.1 Injection General Anesthetics Drug Market: Region Footprint
    • 3.5.2 Injection General Anesthetics Drug Market: Company Product Type Footprint
    • 3.5.3 Injection General Anesthetics Drug Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Injection General Anesthetics Drug Market Size by Region
    • 4.1.1 Global Injection General Anesthetics Drug Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Injection General Anesthetics Drug Consumption Value by Region (2021-2032)
    • 4.1.3 Global Injection General Anesthetics Drug Average Price by Region (2021-2032)
  • 4.2 North America Injection General Anesthetics Drug Consumption Value (2021-2032)
  • 4.3 Europe Injection General Anesthetics Drug Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Injection General Anesthetics Drug Consumption Value (2021-2032)
  • 4.5 South America Injection General Anesthetics Drug Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Injection General Anesthetics Drug Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Injection General Anesthetics Drug Sales Quantity by Type (2021-2032)
  • 5.2 Global Injection General Anesthetics Drug Consumption Value by Type (2021-2032)
  • 5.3 Global Injection General Anesthetics Drug Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Injection General Anesthetics Drug Sales Quantity by Application (2021-2032)
  • 6.2 Global Injection General Anesthetics Drug Consumption Value by Application (2021-2032)
  • 6.3 Global Injection General Anesthetics Drug Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Injection General Anesthetics Drug Sales Quantity by Type (2021-2032)
  • 7.2 North America Injection General Anesthetics Drug Sales Quantity by Application (2021-2032)
  • 7.3 North America Injection General Anesthetics Drug Market Size by Country
    • 7.3.1 North America Injection General Anesthetics Drug Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Injection General Anesthetics Drug Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Injection General Anesthetics Drug Sales Quantity by Type (2021-2032)
  • 8.2 Europe Injection General Anesthetics Drug Sales Quantity by Application (2021-2032)
  • 8.3 Europe Injection General Anesthetics Drug Market Size by Country
    • 8.3.1 Europe Injection General Anesthetics Drug Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Injection General Anesthetics Drug Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Injection General Anesthetics Drug Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Injection General Anesthetics Drug Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Injection General Anesthetics Drug Market Size by Region
    • 9.3.1 Asia-Pacific Injection General Anesthetics Drug Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Injection General Anesthetics Drug Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Injection General Anesthetics Drug Sales Quantity by Type (2021-2032)
  • 10.2 South America Injection General Anesthetics Drug Sales Quantity by Application (2021-2032)
  • 10.3 South America Injection General Anesthetics Drug Market Size by Country
    • 10.3.1 South America Injection General Anesthetics Drug Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Injection General Anesthetics Drug Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Injection General Anesthetics Drug Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Injection General Anesthetics Drug Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Injection General Anesthetics Drug Market Size by Country
    • 11.3.1 Middle East & Africa Injection General Anesthetics Drug Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Injection General Anesthetics Drug Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Injection General Anesthetics Drug Market Drivers
  • 12.2 Injection General Anesthetics Drug Market Restraints
  • 12.3 Injection General Anesthetics Drug Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Injection General Anesthetics Drug and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Injection General Anesthetics Drug
  • 13.3 Injection General Anesthetics Drug Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Injection General Anesthetics Drug Typical Distributors
  • 14.3 Injection General Anesthetics Drug Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Injection General Anesthetics Drug. Industry analysis & Market Report on Injection General Anesthetics Drug is a syndicated market report, published as Global Injection General Anesthetics Drug Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Injection General Anesthetics Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report